GC
DMK

Greenlight Capital’s DMK Pharmaceuticals Corporation Common Stock DMK Stock Holding History

Greenlight Capital’s Portfolio DMK Stock Details DMK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-4,177
Closed -$283K – 62
2021
Q3 		$283K Sell
4,177
-10,109
-71% -$740K 0.02% 48
2021
Q2 		$1.1M Buy
+14,286
New +$870K 0.07% 51

Other funds holding DMK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
VF
Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Greenlight Capital's DMK Position: Q4 2021 in Review

Greenlight Capital sold out of DMK Pharmaceuticals Corporation Common Stock (DMK) in Q4 2021, closing a stake of 4,177 shares — an estimated $283K sold.

Greenlight Capital first reported a position in DMK in Q2 2021 and held it in 2 quarters. The position peaked at $1.1M in Q2 2021. 49 funds tracked by Wall St. Rank hold DMK as of Q4 2021.

  • Greenlight Capital reported no remaining DMK Pharmaceuticals Corporation Common Stock position as of Q4 2021 after selling out during the quarter.
  • Greenlight Capital sold 4,177 DMK Pharmaceuticals Corporation Common Stock shares in Q4 2021, an estimated $283K.
  • Greenlight Capital first reported a position in DMK Pharmaceuticals Corporation Common Stock in Q2 2021 and held it in 2 quarters.
  • Greenlight Capital's DMK Pharmaceuticals Corporation Common Stock position peaked at $1.1M in Q2 2021.
  • 49 funds tracked by Wall St. Rank held DMK Pharmaceuticals Corporation Common Stock as of Q4 2021.

Based on Greenlight Capital's 13F filing for Q4 2021, filed 14 Feb 2022.